| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/14/2002 | CA2389602A1 Methods and compositions for potentiating cancer chemotherapeutic agents |
| 03/13/2002 | EP1186610A1 Dicarboxylato diammine platinum derivatives and compositions comprising them as anti-tumor agents |
| 03/13/2002 | EP1186606A1 Epothilone derivatives, their preparation and utilization |
| 03/13/2002 | EP1186603A2 Processes for preparing endothelin antagonists |
| 03/13/2002 | EP1186319A1 Use of serum response factor (SRF) modulator for treating SRF related diseases |
| 03/13/2002 | EP1186301A2 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations |
| 03/13/2002 | EP1185700A1 49 human secreted proteins |
| 03/13/2002 | EP1185696A1 Antisense oligonucleotide modulation of human protein kinase c-delta expression |
| 03/13/2002 | EP1185694A1 49 human secreted proteins |
| 03/13/2002 | EP1185681A1 High specificity hairpin antisense oligonucleotides |
| 03/13/2002 | EP1185666A1 Hyaluronidase from the hirudinaria manillensis, isolation, purification and recombinant method of production |
| 03/13/2002 | EP1185652A2 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto |
| 03/13/2002 | EP1185649A2 The myostatin gene promoter and inhibition of activation thereof |
| 03/13/2002 | EP1185648A2 Methods and compositions for inhibiting neoplastic cell growth |
| 03/13/2002 | EP1185642A2 Compositions and methods for the treatment of tumor |
| 03/13/2002 | EP1185639A1 Prostate-specific gene, pcgem1, and methods of using pcgem1 to detect, treat, and prevent prostate cancer |
| 03/13/2002 | EP1185632A1 Caspase-8 crystals, models and methods |
| 03/13/2002 | EP1185626A2 A method for the transfer of antigens to dendritic cells |
| 03/13/2002 | EP1185620A2 Spheroid preparation |
| 03/13/2002 | EP1185618A1 A bacterial strain, processed plant extracts and probiotic compositions for human and veterinary use |
| 03/13/2002 | EP1185559A2 Compositions and methods for cancer treatment by selectively inhibiting vegf |
| 03/13/2002 | EP1185557A1 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
| 03/13/2002 | EP1185555A2 Compositions isolated from skin cells and methods for their use |
| 03/13/2002 | EP1185554A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof |
| 03/13/2002 | EP1185543A1 50 human secreted proteins |
| 03/13/2002 | EP1185540A1 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents |
| 03/13/2002 | EP1185536A2 Hemisynthetic method and intermediates thereof |
| 03/13/2002 | EP1185535A1 Cyclocarbamate and cyclic amide derivatives |
| 03/13/2002 | EP1185532A1 Peroxynitrite decomposition catalysts and methods of use thereof |
| 03/13/2002 | EP1185530A1 Imidazo- and pyrrolo[1,2-a]pyrimid-4-ones as gonadotropin-releasing hormone receptor antagonists |
| 03/13/2002 | EP1185529A1 Pyrazolobenzodiazepines as cdk2 inhibitors |
| 03/13/2002 | EP1185516A1 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect |
| 03/13/2002 | EP1185493A1 Quinones for treatment of diseases |
| 03/13/2002 | EP1185306A1 Use of viral vectors and charged molecules for gene therapy |
| 03/13/2002 | EP1185304A2 Conjugates comprising cytokines and nucleic acids for treating proliferating cells |
| 03/13/2002 | EP1185300A1 Method of treating carcinoma using antibody therapy and ameliorating side effects associated with such therapy |
| 03/13/2002 | EP1185296A2 Prevention and treatment of amyloidogenic disease |
| 03/13/2002 | EP1185285A1 49 human secreted proteins |
| 03/13/2002 | EP1185284A1 47 human secreted proteins |
| 03/13/2002 | EP1185279A2 Agents for treating malignant diseases using e1a-deficient adenoviruses with yb-1 protein-dependent replication |
| 03/13/2002 | EP1185277A1 Methods for modulating fxr receptor activity |
| 03/13/2002 | EP1185276A1 Isophosphoramide mustard analogs and use thereof |
| 03/13/2002 | EP1185249A2 Methods and compositions for treating solid tumors |
| 03/13/2002 | EP1185175A1 Method of increasing the content of flavonoids and phenolic substances in plants |
| 03/13/2002 | EP1185169A2 USE OF TRANSGENIC MICE LACKING JunB EXPRESSION IN THE MYELOID LINEAGE |
| 03/13/2002 | EP0977749B1 Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same |
| 03/13/2002 | EP0948483B1 Farnesyl transferase inhibitors |
| 03/13/2002 | EP0876343B1 Aromatic keto-acids and their derivatives as inhibitors of matrix metalloproteinases |
| 03/13/2002 | EP0869805B1 Method for preparation of active substances from nacre, resulting products, useful in medicinal applications |
| 03/13/2002 | EP0841909B1 Use of alicyclic diamines as immunomodulators |
| 03/13/2002 | EP0802910B1 Estrogen agonists/antagonists |
| 03/13/2002 | EP0721342B1 Polypeptides of the semaphorin gene family |
| 03/13/2002 | CN1340103A Complex-forming proteins |
| 03/13/2002 | CN1340102A Polypeptide variants with raised heparin-binding capacity |
| 03/13/2002 | CN1340098A Astrocytes, their preparation and use thereof |
| 03/13/2002 | CN1340059A Peptides |
| 03/13/2002 | CN1340058A Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 03/13/2002 | CN1340057A Synthetic poly peptide disturbing intracelluler signaling |
| 03/13/2002 | CN1340056A Steroides sulfatase inhibitors and methods for making and using same |
| 03/13/2002 | CN1340054A 2-amino-6-anilino-purines and their use as medicaments |
| 03/13/2002 | CN1340053A Epothilon derivatives, method for the production and the use as pharmaceuticals |
| 03/13/2002 | CN1340051A Heteroaryl-substituted quinoline-2-one derivatives useful asticancer agents |
| 03/13/2002 | CN1340049A 4-heterocyclylsulfonamide)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl-or-pyridylpyrimidines as endothelin receptor antagonists |
| 03/13/2002 | CN1340046A β－丙氨酸衍生物 β- alanine derivatives |
| 03/13/2002 | CN1339971A Application polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of tumor and diabetes mellitus |
| 03/13/2002 | CN1339970A Anticancer agent potentiators |
| 03/13/2002 | CN1339969A Liposone composition and method for administration of a radiosensitizer |
| 03/13/2002 | CN1339963A Spontaneously dispersible N-benzoyl staurosporine compositions |
| 03/13/2002 | CN1339955A Gels formed by the interaction of poly(aldehyde) with various sabstances |
| 03/13/2002 | CN1339599A New polypeptide-phosphotadic acid phosphatase 29.81 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339590A New polypeptide-human dehydroggenase 29.15 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339584A Recombined virus for specific proliferation and high efficiency expression of anti-cancer gene in tumor cells and its constitution method |
| 03/13/2002 | CN1339583A Recombined smegmatis mycobacterium, its preparation and use in medicine for treating bladder tumor |
| 03/13/2002 | CN1339456A New polypeptide-membrane-spanning protein 35.31 with epidermal growth factor liker repeating functional domain and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339442A Schizophyllary tetrasaccharide cluster compound and its preparing method and use |
| 03/13/2002 | CN1339440A Process for producing super critical extracting caterpillar fungus deoxynucleoside |
| 03/13/2002 | CN1339304A Process for preparing 'xueaisan' as blood cancer curing medicine powder |
| 03/13/2002 | CN1080720C 噻唑衍生物 Thiazole derivatives |
| 03/13/2002 | CN1080718C Vitamin D amine and amine derivatives |
| 03/13/2002 | CN1080563C Use of sunflower stalk core as medicinal preparation for treating cancer |
| 03/12/2002 | US6355809 Method for preparing (2s)-1-(2r3s)-5-chloro-3-(2-chlorophenyl) -1-(3,4-dimethoxy benzene-sulphonyl) 3-hydroxy-2,3-dihydro-1h-indole-2-carbonyl pyrrolidine-2-carboxamide |
| 03/12/2002 | US6355774 Isolated p27 protein |
| 03/12/2002 | US6355678 Inhibitors of the EGF-receptor tyrosine kinase and methods for their use |
| 03/12/2002 | US6355673 Substituted diaminocarboxylic acids |
| 03/12/2002 | US6355670 Skin disorders |
| 03/12/2002 | US6355666 Protected forms of pharmacologically active agents and uses therefor |
| 03/12/2002 | US6355658 Coumarin derivatives, methods of preparation and application as medicines |
| 03/12/2002 | US6355648 Thio-oxindole derivatives |
| 03/12/2002 | US6355643 Enzyme inhibitors, ras genes and proteins |
| 03/12/2002 | US6355636 Enzyme inhibitors |
| 03/12/2002 | US6355632 Naphthyl compounds, intermediates, compositions, and methods |
| 03/12/2002 | US6355628 Combination therapy using pentafluorobenzenesulfonamides |
| 03/12/2002 | US6355622 Use of a melanoma differentiation associated gene (mda-7) for inducing apoptosis of a tumor cell |
| 03/12/2002 | US6355619 Chemokines to cognate alpha-chemokine receptors and antitumor agents |
| 03/12/2002 | US6355618 Enzyme inhibitors |
| 03/12/2002 | US6355613 Cyclized oligopeptides with bridging groups of amide, thioether, thioester or disulfide |
| 03/12/2002 | US6355611 Salt form of a conjugate useful in the treatment of prostate cancer |
| 03/12/2002 | US6355483 Antisense nucleotides for use in the treatment of leukemia |
| 03/12/2002 | US6355475 Generating fungal culture; obtain fungus, incculate and propagate fungus harvesting the culture |
| 03/12/2002 | US6355474 Generating antiproliferative agents; obtain wheat, ferment, separate, fine filter, boil, evaporate and recover dried material |